Calcium acetate-induced linear fixed drug eruption [4]

Dermatology

Volumn 210, Issue 3, 2005, Pages 244-245

  Coskun, Basak ^a   Saral, Yunus ^a   Ozturk, Perihan ^a   Karincaoglu, Yelda ^b   Cobanoglu, Bengu ^a  

^a FIRAT UNIVERSITY   (Turkey)

^b INONU UNIVERSITY   (Turkey)

Author keywords

Calcium acetate; Linear fixed drug eruption

Indexed keywords

CALCIUM ACETATE;

ADULT; CASE REPORT; CELL INFILTRATION; CHRONIC KIDNEY FAILURE; DERMIS; DRUG ERUPTION; DRUG INDUCED DISEASE; FOREARM; HISTOPATHOLOGY; HUMAN; HYPERKERATOSIS; HYPERPIGMENTATION; INFLAMMATORY CELL; LETTER; MALE; PATIENT; PHYSICAL EXAMINATION; PRIORITY JOURNAL; PROVOCATION TEST; PRURITUS; SHOULDER; SKIN BIOPSY; SKIN CELL; SKIN EPITHELIUM; SKIN EXAMINATION; SKIN PIGMENTATION;

ACETATES; DIAGNOSIS, DIFFERENTIAL; DRUG ERUPTIONS; HUMANS; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED;

EID: 17244368251     PISSN: 10188665     EISSN: None     Source Type: Journal    
DOI: 10.1159/000083961     Document Type: Letter

References (16)

1. Mahobob A, Haroon TS: Drugs causing fixed drug eruption: A study of 450 cases. Int J Dermatol 1998;37:833-838.
2. Li H, Wiederkehr M, Rao B, Samady J-A, Gardner B, Lambert C, Schwartz RA: Peculiar unilateral fixed drug eruption of the breast. Int J Dermatol 2002;42:96-98.
3. Teraki Y, Moriya N, Shiohara T: Drug- induced expression of intercellular adhesion molecule 1 on lesional keratinocytes in fixed drug eruption. Am J Pathol 1994;145:550-560.
4. Shiohara T, Moriya N: Epidermal T cells: Their functional role and disease relevance for dermatologists. J Invest Dermatol 1997;109:271-275.
5. 22. J Am Acad Dermatol 1994;30:52-54.
6. Hofer T. Lichen striatus in adults or 'adult blaschkitis'? There is no need for a new naming. Dermatology 2003;207:89-92.
7. Utikal J, Keil D, Klemke CD, Bayerl C, Goerdt S. Predominant telangiectatic erythema in linear atrophoderma of Moulin: Novel variant or separate entity? Dermatology 2003;207:310-315.
8. Horn T: Cutaneous toxicities of drugs; in Lever WF, Schaumburg-Lever G (eds): Histopathology of the Skin. Philadelphia, Lippincott, 1990, pp 287-303.
9. Moss C: Cytogenetic and molecular evidence for cutaneous mosaicism: The ectodermal origin of Blaschko lines. Am J Med Genet 1999;85:330-333.
10. Happle R: New aspects of cutaneous mosaicism. J Dermatol 2002;29:681-692.
11. Bologna JL, Orlow SJ, Glick SA: Lines of Blaschko. J Am Acad Dermatol 1994;31:157-190.
12. Lipsker D, Cribier B, Girard-Lemaire F, Flori E, Grosshans E: Genetic mosaicism in an acquired inflammatory dermatosis following the lines of Blaschko. Arch Dermatol 2000;136:805-807.
13. Ozkaya-Bayazit E, Bayazit H, Ozarmagan G: Drug related clinical pattern in fixed drug eruption. Eur J Dermatol 2000;10:288-291.
14. Sehgal VN, Gangwani OP: Fixed drug eruption: Current concepts. Int J Dermatol 1987;26:67-74.
15. Sigal-Nahum M, Kongui A, Gaulier A, Sigal S: Linear fixed drug eruption. Br J Dermatol 1988;118:849-851.
16. Ozkaya-Bayazit E, Baykal C: Trimethoprim induced linear fixed drug eruption. Br J Dermatol 1997;137:1028-1029.